These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 2778368

  • 21. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
    Katoch K, Natarajan M, Bagga A, Katoch VM.
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):248-54. PubMed ID: 2071982
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of two multidrug regimen in hospitalised multibacillary cases.
    Chattopadhyay SP, Gupta CM, Bhate RD, Bhate RP, Sreevatsa.
    Indian J Lepr; 1989 Apr; 61(2):196-205. PubMed ID: 2746028
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK, Girdhar A, Natrajan M, Kumar A, Girdhar BK.
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
    Kaur I, Dogra S, Kumar B, Radotra BD.
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of fixed duration therapy.
    Mathew D, Kishore BN, Shwethadri GK, Sukumar, Shetty NJ.
    Indian J Lepr; 2004 Sep; 76(1):11-8. PubMed ID: 15527055
    [Abstract] [Full Text] [Related]

  • 33. Fixed-duration multidrug therapy in multibacillary leprosy.
    Li HY, Hu LF, Wu PW, Luo JS, Liu XM.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596
    [Abstract] [Full Text] [Related]

  • 34. Multidrug therapy in leprosy.
    Manglani PR, Arif MA.
    J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
    [Abstract] [Full Text] [Related]

  • 35. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
    Levis WR, Spencer TI, Ladizinski B.
    J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
    [No Abstract] [Full Text] [Related]

  • 36. A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
    Kar PK, Arora PN, Ramasastry CV, Dhaka RS.
    J Indian Med Assoc; 1994 Oct; 92(10):336-7. PubMed ID: 7822849
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G, Janssens L, Kayembe T, Nollet E, Coussens L, Pattyn SR.
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Fixed-duration therapy (FDT) in multibacillary leprosy; efficacy and complications.
    Vijayakumaran P, Jesudasan K, Manimozhi N.
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):123-7. PubMed ID: 8690969
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.